L-kynurenine as a prognostic marker for early mortality in patients with acute myeloid leukemia.

Kierdorf, Fiona; Zimmer, Philipp; Joisten, Niklas; Kiesl, David; Winker, Matteo; Rigoux, Lionel; Elter, Thomas

Kierdorf, Fiona; Zimmer, Philipp; Joisten, Niklas; Kiesl, David; Winker, Matteo; Rigoux, Lionel; Elter, Thomas.

Affiliation

Kierdorf F; Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.
Zimmer P; Division of Performance and Health (Sport Medicine), Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.
Joisten N; Division of Performance and Health (Sport Medicine), Institute for Sport and Sport Science, TU Dortmund University, Dortmund, Germany.
Kiesl D; Department of Hematology and Internal Oncology, Kepler University Linz, Linz, Austria.
Winker M; Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.
Rigoux L; Max-Planck-Institute for Metabolism Research, Cologne, Germany.
Elter T; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Köln, Germany.

Leuk Lymphoma ; 63(8): 2001-2004, 2022 08.

Article in En | MEDLINE | ID: mdl-35357984

Subject(s)

Kynurenine; Leukemia, Myeloid, Acute; Antineoplastic Combined Chemotherapy Protocols; Humans; Prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Kynurenine Type of study: Prognostic_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google